← Back to patent-cliff list
Yttrium-90 Carbon Microspheres
Tier C — Watch / tradeYttrium-90 Carbon Microspheres
Zhongda Hospital Southeast University
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Colon cancer, Metastatic cancer
Regional status
US
-
EU
-
China
Phase II
2022-12-28
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Yttrium-90 Carbon Microspheres?
Approved indications include: Colon cancer, Metastatic cancer.
When does the Yttrium-90 Carbon Microspheres patent expire?
No public expiry year is available for Yttrium-90 Carbon Microspheres yet; this page updates once verified.
How do I get a quote for Yttrium-90 Carbon Microspheres intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03